TRIUMPH-1 trajectory (80 weeks + extension): Week 80: 28.3% average weight loss (2,339 patients) 104-week extension (BMI 35 subgroup): 30.3% average weight loss Weight loss does not plateau at 80 weeks it continues in longer treatment The TRIUMPH-1 104-week extension is the most important long-term efficacy signal we have
This lets healthcare providers withdraw several doses from one container
A Word About Compounded GLP-1s Because brand-name versions like Ozempic and Wegovy can be expensive, and their injection pens arent designed for microdosed use, some healthcare providers are turning to compounding pharmacies to source GLP-1 medications
Rather than presenting testimonials or making outcome guarantees, the most helpful approach for potential users is a self-qualification framework
A separate Phase 2 sub-study published in 2024 in Nature Medicine looked specifically at participants with non-alcoholic fatty liver disease (NAFLD) a condition where fat accumulates in the liver and can progress to serious disease
Research published in the Journal of Biological Chemistry established that GHK-Cu upregulates TGF-1 and TGF-2 expression in fibroblast models while simultaneously suppressing TGF--induced Smad3 phosphorylation under inflammatory conditions